James S. Blachly

机构：The Ohio State University Wexner Medical Center, The Ohio State University, Indiana University – Purdue University Columbus · ORCID：0000-0002-4275-5562

发表论文 460 篇 · 总被引 6505 次 · h-index 42

代表论文

• Data from Phase 1 Study of KITE-222, an Autologous CLL-1–Directed CAR T-cell Therapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia (2026 · 被引 1)
• Supplemental Table 9 from Phase 1 Study of KITE-222, an Autologous CLL-1–Directed CAR T-cell Therapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia (2026)
• Supplemental Table 9 from Phase 1 Study of KITE-222, an Autologous CLL-1–Directed CAR T-cell Therapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia (2026)
• Supplemental Table 2 from Phase 1 Study of KITE-222, an Autologous CLL-1–Directed CAR T-cell Therapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia (2026)
• Supplemental Table 7 from Phase 1 Study of KITE-222, an Autologous CLL-1–Directed CAR T-cell Therapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia (2026)
• Supplemental Table 8 from Phase 1 Study of KITE-222, an Autologous CLL-1–Directed CAR T-cell Therapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia (2026)